|
|
Volumn 10, Issue 2, 2001, Pages 128-140
|
|
What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Viewpoints
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIALLERGIC AGENT;
BU ZHONG YI QI TANG;
CD3 ANTIGEN;
CD4 ANTIGEN;
CHEMOKINE;
CHEMOKINE RECEPTOR;
CYCLOSPORIN A;
CYTOKINE;
CYTOKINE ANTIBODY;
CYTOKINE RECEPTOR;
GAMMA INTERFERON;
HERBACEOUS AGENT;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN E;
IMMUNOGLOBULIN E RECEPTOR;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 13;
INTERLEUKIN 4;
INTERLEUKIN 5;
LEUKOTRIENE B4;
OLIGONUCLEOTIDE;
PHOSPHODIESTERASE INHIBITOR;
PSORALEN;
SUPLATAST TOSYLATE;
T LYMPHOCYTE ANTIBODY;
T LYMPHOCYTE RECEPTOR;
TACROLIMUS;
UNINDEXED DRUG;
ADENOSINE A2 RECEPTOR;
BENZODIAZEPINE;
CD81 ANTIGEN;
CYTOKININ;
HISTAMINE RECEPTOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
PROSTANOID RECEPTOR;
TUMOR NECROSIS FACTOR;
VACCINE;
ALLERGIC DISEASE;
ATOPIC DERMATITIS;
ATOPY;
CHINESE HERB;
DRUG EFFICACY;
DRUG SPECIFICITY;
DRUG TARGETING;
EOSINOPHIL;
HEALTH CARE MANAGEMENT;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
IMMUNOTHERAPY;
LANGERHANS CELL;
MACROPHAGE;
MAST CELL;
MONOCYTE;
NOTE;
PATHOGENESIS;
PHOTOCHEMOTHERAPY;
T LYMPHOCYTE;
TH1 CELL;
TH2 CELL;
TREATMENT PLANNING;
ULTRAVIOLET A RADIATION;
VACCINATION;
ALLERGENICITY;
ASTHMA;
AUTOIMMUNE DISEASE;
BACTERIUM;
CELL ACTIVATION;
CONTACT DERMATITIS;
DEFENSE MECHANISM;
EFFECTOR CELL;
IMMUNOPATHOLOGY;
NONHUMAN;
PATHOPHYSIOLOGY;
REGULATORY MECHANISM;
RHINITIS;
SKIN ALLERGY;
SKIN ANAPHYLAXIS;
VIRUS;
|
|
EID: 0035086822
PISSN: 09066705
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0625.2001.010002128.x Document Type: Note |
|
Times cited : (10)
|
|
References (139)
|
